INVIVYD ALERT: Bragar Eagel & Squire, P.C. is Investigating Invivyd, I...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 9, 2023

Saudi Arabia: Modern means of transportation for easier Hajj • Sophisticated Utility Vehicle: all-new 2024 Lexus GX Redefines SUV • IgGenix Demonstrates Potential for an IgG4 Monoclonal Antibody-based Approach to Treating Peanut Allergy • SoftwareReviews Reveals the Top ESG Software Solutions That Enable Organizations to Build a Culture of Purpose and Sustainabilit • A New Era of Three-Row Luxury: The First-Ever Lexus TX • Providing LGBTQI+ people with a safe home in Canada • Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematol • Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presen • TIO EQUITY ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Tingo Group, Inc. Investors with Losses in Excess of $100K to Secur • USCIB Releases Pride Month Statement, Supporting Equality and Inclusion • Stallergenes Greer Showcases Clinical Relevance and Persisting Benefits of Its Allergen Immunotherapy Treatments at 2023 EAACI C • Hengtong Optic-Electric Releases 2022 ESG Report at the PT Expo • ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at • Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 • Children's Miracle Network Hospitals® Celebrates 40th Anniversary with Celebrity Friends and Supporters • Fairmont Mayakoba to host exclusive 2023 pride celebration • CGTN: China stresses green development, ethnic unity in modernization drive • Perfuze Announces Appointment of New Chair of the Board • Ventas Realty, Limited Partnership Announces Upsize and Pricing of $750 Million of Exchangeable Senior Notes • BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congres

INVIVYD ALERT: Bragar Eagel & Squire, P.C. is Investigating Invivyd, Inc. on Behalf of Long-Term Stockholders and Encourages

NEW YORK , May 27 /Businesswire/ - Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Invivyd, Inc. (NASDAQ: IVVD) on behalf of long-term stockholders following a class action complaint that was filed against Invivyd on January 31, 2023 with a Class Period from November 29, 2021 to December 14, 2021. Our investigation concerns whether the board of directors of Invivyd have breached their fiduciary duties to the company.

The plaintiff alleges that, the defendants failed to disclose that the published epitope mapping, structural studies, and sequence analyses which defendants had used to claim ADG20 was effective against the Omicron variant were insufficient, unreliable, and inadequate to make claims of effectiveness of ADG20 against Omicron, that that defendants' claims regarding ADG20's efficacy against Omicron lacked a reasonable factual basis, and that ADG20 was over 300 times less effective against the Omicron variant as compared to its effectiveness against previous variants.

If you are a long-term stockholder of Invivyd, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.